<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Vitrolife Ab — News on 6ix</title>
<link>https://6ix.com/company/vitrolife-ab</link>
<description>Latest news and press releases for Vitrolife Ab on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 03 Feb 2026 07:25:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/vitrolife-ab" rel="self" type="application/rss+xml" />
<item>
<title>Vitrolife AB (publ) - Fourth quarter and full year report 2025</title>
<link>https://6ix.com/company/vitrolife-ab/news/vitrolife-ab-publ-fourth-quarter-072500983</link>
<guid isPermaLink="true">https://6ix.com/company/vitrolife-ab/news/vitrolife-ab-publ-fourth-quarter-072500983</guid>
<pubDate>Tue, 03 Feb 2026 07:25:00 GMT</pubDate>
<description>Vitrolife AB (publ) - Fourth quarter and full year report 2025</description>
</item>
<item>
<title>Invitation to Vitrolife Group's presentation of the fourth quarter and full year report 2025</title>
<link>https://6ix.com/company/vitrolife-ab/news/invitation-vitrolife-groups-presentation-fourth-170900730</link>
<guid isPermaLink="true">https://6ix.com/company/vitrolife-ab/news/invitation-vitrolife-groups-presentation-fourth-170900730</guid>
<pubDate>Tue, 20 Jan 2026 17:09:00 GMT</pubDate>
<description>Vitrolife AB (publ) will publish its fourth quarter and full year report 2025 on Tuesday, 3 February 2026 at 08:00 am CET. A conference call for investors, analysts and financial media will be held at 10:00 am CET the same day.</description>
</item>
<item>
<title>Vitrolife announces genetic services restructuring program targeting annualised savings of 65 MSEK and recognises a 5.4 BSEK goodwill impairment</title>
<link>https://6ix.com/company/vitrolife-ab/news/vitrolife-announces-genetic-services-restructuring-185500483</link>
<guid isPermaLink="true">https://6ix.com/company/vitrolife-ab/news/vitrolife-announces-genetic-services-restructuring-185500483</guid>
<pubDate>Tue, 16 Dec 2025 18:55:00 GMT</pubDate>
<description>Vitrolife AB (publ) ("Vitrolife") today announced that following a strategic review it will execute a restructuring program of its genetic services business. The program is targeting annualised savings of SEK 65 million, expected to have a positive impact in the first half of 2026, and to reach full effect by the end of the third quarter 2026. Furthermore, Vitrolife will record a goodwill impairment of SEK 5.4 billion in Q4 2025, related to the Igenomix acquisition.</description>
</item>
<item>
<title>Nomination committee of Vitrolife AB (publ) for the Annual General Meeting 2026</title>
<link>https://6ix.com/company/vitrolife-ab/news/nomination-committee-vitrolife-ab-publ-082500390</link>
<guid isPermaLink="true">https://6ix.com/company/vitrolife-ab/news/nomination-committee-vitrolife-ab-publ-082500390</guid>
<pubDate>Wed, 29 Oct 2025 08:25:00 GMT</pubDate>
<description>In accordance with the Nomination Committee Charter adopted at the Annual General Meeting 2025, the members who, together with the Chair of the Board, constitute the Nomination Committee in preparation of the Annual General Meeting 2026 have been elected.</description>
</item>
<item>
<title>Vitrolife AB (publ) - Interim report Q3, 2025: Strong growth in Americas</title>
<link>https://6ix.com/company/vitrolife-ab/news/vitrolife-ab-publ-interim-report-063800201</link>
<guid isPermaLink="true">https://6ix.com/company/vitrolife-ab/news/vitrolife-ab-publ-interim-report-063800201</guid>
<pubDate>Thu, 23 Oct 2025 06:38:00 GMT</pubDate>
<description>Vitrolife AB (publ) - Interim report Q3, 2025: Strong growth in Americas</description>
</item>
<item>
<title>Invitation to Vitrolife Group's presentation of the Q3 2025 interim report</title>
<link>https://6ix.com/company/vitrolife-ab/news/invitation-vitrolife-groups-presentation-q3-081000666</link>
<guid isPermaLink="true">https://6ix.com/company/vitrolife-ab/news/invitation-vitrolife-groups-presentation-q3-081000666</guid>
<pubDate>Thu, 09 Oct 2025 08:10:00 GMT</pubDate>
<description>Vitrolife AB (publ) will publish its Q3 2025 interim report on Thursday, 23 October 2025 at 08:00 am CEST. A conference call for investors, analysts and financial media will be held at 10:00 am CEST the same day.</description>
</item>
<item>
<title>Vitrolife AB: Interim report Q2, 2025: Strong performance across Consumables</title>
<link>https://6ix.com/company/vitrolife-ab/news/vitrolife-ab-interim-report-q2-061000344</link>
<guid isPermaLink="true">https://6ix.com/company/vitrolife-ab/news/vitrolife-ab-interim-report-q2-061000344</guid>
<pubDate>Thu, 17 Jul 2025 06:10:00 GMT</pubDate>
<description>Vitrolife AB: Interim report Q2, 2025: Strong performance across Consumables</description>
</item>
<item>
<title>Invitation to Vitrolife Group's presentation of the Q2 2025 interim report</title>
<link>https://6ix.com/company/vitrolife-ab/news/invitation-vitrolife-groups-presentation-q2-122000842</link>
<guid isPermaLink="true">https://6ix.com/company/vitrolife-ab/news/invitation-vitrolife-groups-presentation-q2-122000842</guid>
<pubDate>Thu, 03 Jul 2025 12:20:00 GMT</pubDate>
<description>Vitrolife AB (publ) will publish its Q2 2025 interim report on Thursday, 17 July 2025 at 08:00 am CEST. A conference call for investors, analysts and financial media will be held at 10:00 am CEST the same day.</description>
</item>
<item>
<title>Vitrolife Group completes refinancing facility backed by leading Nordic Banks</title>
<link>https://6ix.com/company/vitrolife-ab/news/vitrolife-group-completes-refinancing-facility-091300376</link>
<guid isPermaLink="true">https://6ix.com/company/vitrolife-ab/news/vitrolife-group-completes-refinancing-facility-091300376</guid>
<pubDate>Tue, 01 Jul 2025 09:13:00 GMT</pubDate>
<description>Vitrolife AB (publ) has today renewed and signed a loan agreement of EUR 300 million comprising of term loan and revolving credit facility. The term loan will be used to refinance existing debt and the revolving credit facility will be available for general corporate purposes.</description>
</item>
<item>
<title>Vitrolife AB (publ) becomes lead investor in AutoIVF</title>
<link>https://6ix.com/company/vitrolife-ab/news/vitrolife-ab-publ-becomes-lead-140600529</link>
<guid isPermaLink="true">https://6ix.com/company/vitrolife-ab/news/vitrolife-ab-publ-becomes-lead-140600529</guid>
<pubDate>Thu, 08 May 2025 14:06:00 GMT</pubDate>
<description>The Vitrolife Group today announces it has become a leading investor in AutoIVF. This strategic investment aligns with our corporate strategy of improving affordability and access to IVF to patients around the world.</description>
</item>
<item>
<title>Report from Annual General Meeting of Vitrolife AB (publ)</title>
<link>https://6ix.com/company/vitrolife-ab/news/report-annual-general-meeting-vitrolife-072500032</link>
<guid isPermaLink="true">https://6ix.com/company/vitrolife-ab/news/report-annual-general-meeting-vitrolife-072500032</guid>
<pubDate>Wed, 30 Apr 2025 07:25:00 GMT</pubDate>
<description>At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided:</description>
</item>
<item>
<title>Vitrolife AB (publ) Interim report Q1, 2025: Strong performance in EMEA</title>
<link>https://6ix.com/company/vitrolife-ab/news/vitrolife-ab-publ-interim-report-061700206</link>
<guid isPermaLink="true">https://6ix.com/company/vitrolife-ab/news/vitrolife-ab-publ-interim-report-061700206</guid>
<pubDate>Thu, 24 Apr 2025 06:17:00 GMT</pubDate>
<description>Vitrolife AB (publ) Interim report Q1, 2025: Strong performance in EMEA</description>
</item>
<item>
<title>The Vitrolife Group appoints Pär Ihrskog as the new Chief Financial Officer</title>
<link>https://6ix.com/company/vitrolife-ab/news/vitrolife-group-appoints-p-r-103100516</link>
<guid isPermaLink="true">https://6ix.com/company/vitrolife-ab/news/vitrolife-group-appoints-p-r-103100516</guid>
<pubDate>Thu, 10 Apr 2025 10:31:00 GMT</pubDate>
<description>Pär Ihrskog has been appointed CFO of the Vitrolife Group effective 10 October 2025. Pär currently serves as CFO at Bufab Group and brings a wealth of experience to the company, having also served as Group CFO/CIO at Embellence Group. He spent the majority of his career working in finance roles, of increasing seniority in SKF, also living and working in several countries, including the U.S. and China. Pär holds a master's degree in business administration.</description>
</item>
<item>
<title>Conference call interim report</title>
<link>https://6ix.com/company/vitrolife-ab/news/conference-call-interim-report-083100875</link>
<guid isPermaLink="true">https://6ix.com/company/vitrolife-ab/news/conference-call-interim-report-083100875</guid>
<pubDate>Thu, 10 Apr 2025 08:31:00 GMT</pubDate>
<description>Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q1 2025. The presentation will be held in English.</description>
</item>
<item>
<title>The Vitrolife Group introduces changes to the executive management team and strengthens focus on innovation</title>
<link>https://6ix.com/company/vitrolife-ab/news/vitrolife-group-introduces-changes-executive-124200904</link>
<guid isPermaLink="true">https://6ix.com/company/vitrolife-ab/news/vitrolife-group-introduces-changes-executive-124200904</guid>
<pubDate>Mon, 31 Mar 2025 12:42:00 GMT</pubDate>
<description>To further drive the execution of the Vitrolife Group corporate strategy, the company is evolving the executive management team and introducing a SVP Innovation role to accelerate the pace and output of innovation.</description>
</item>
<item>
<title>Vitrolife Group Annual and Sustainability Report 2024</title>
<link>https://6ix.com/company/vitrolife-ab/news/vitrolife-group-annual-sustainability-report-083600889</link>
<guid isPermaLink="true">https://6ix.com/company/vitrolife-ab/news/vitrolife-group-annual-sustainability-report-083600889</guid>
<pubDate>Thu, 27 Mar 2025 08:36:00 GMT</pubDate>
<description>Vitrolife Group has today published its Annual and Sustainability Report for 2024.</description>
</item>
<item>
<title>Notice to attend the Annual General Meeting of Vitrolife AB (publ)</title>
<link>https://6ix.com/company/vitrolife-ab/news/notice-attend-annual-general-meeting-175300559</link>
<guid isPermaLink="true">https://6ix.com/company/vitrolife-ab/news/notice-attend-annual-general-meeting-175300559</guid>
<pubDate>Tue, 25 Mar 2025 17:53:00 GMT</pubDate>
<description>The shareholders of Vitrolife AB (publ) are hereby invited to attend the Annual General Meeting of shareholders on 29 April 2025 at 4.00 pm at the Elite Park Avenue Hotel, Kungsportsavenyn 36-38 in Gothenburg, Sweden. The entrance opens at 3.30 pm.</description>
</item>
<item>
<title>In light of the recent PGT-A class action lawsuit filings in a court in Florida, Vitrolife Group issues the following statement</title>
<link>https://6ix.com/company/vitrolife-ab/news/light-recent-pgt-class-action-182200084</link>
<guid isPermaLink="true">https://6ix.com/company/vitrolife-ab/news/light-recent-pgt-class-action-182200084</guid>
<pubDate>Wed, 05 Mar 2025 18:22:00 GMT</pubDate>
<description>Vitrolife Group is aware that a PGT-A class action lawsuit has been filed against Vitrolife AB (publ), Vitrolife Inc and Igenomix USA, Inc in the court of the Southern District of Florida, although no formal complaint has been served yet. During the fourth quarter of 2024, similar class actions were initiated in the US against other peer companies providing PGT-A testing services. Vitrolife Group will, together with our legal counsel in the US, evaluate the class action and its potential scope a</description>
</item>
<item>
<title>The Vitrolife Group appoints Ermanno Sironi as Chief Operating Officer</title>
<link>https://6ix.com/company/vitrolife-ab/news/vitrolife-group-appoints-ermanno-sironi-121800187</link>
<guid isPermaLink="true">https://6ix.com/company/vitrolife-ab/news/vitrolife-group-appoints-ermanno-sironi-121800187</guid>
<pubDate>Fri, 21 Feb 2025 12:18:00 GMT</pubDate>
<description>The Vitrolife Group is strengthening the executive management team with the introduction of the role of Chief Operating Officer (COO), appointing Ermanno Sironi to the position effective immediately.</description>
</item>
</channel>
</rss>